On the dual action of ascorbate and erythorbate on rat liver lysosomes.

I Abe, S Saito, K Hori, M Suzuki, H Sato
{"title":"On the dual action of ascorbate and erythorbate on rat liver lysosomes.","authors":"I Abe,&nbsp;S Saito,&nbsp;K Hori,&nbsp;M Suzuki,&nbsp;H Sato","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Low concentration (0.1--1 mM) of ascorbate and erythorbate (isoascorbate) caused lipid peroxidation and lysosome labilization (\"cofactor\" action). In addition, they acted additively on microsomal NADPH oxidase-induced lipid peroxidation at the low concentration. The \"cofactor\" action, however, was dependent reciprocally on the density of lysosomes; the more dilute was the lysosomal fraction, the more susceptible the lysosomes were. On the other hand, ascorbate and erythorbate at concentration more than 1 mM inhibited microsomal NADPH oxidase-induced lipid peroxidation and lysosome labilization. Their antioxidant effect was revealed to be clear especially when the \"cofactor\" action was eliminated by such a basic protein as protamine. Considering that the \"cofactor\" action was observed only at the lower density of lysosomes and might be inhibited by physiologically occurring basic proteins, ascorbate and erythorbate may mostly act as antioxidant on lysosomes in vivo. Ascorbate- or erythorbate- induced lysosome labilization was certified to be mediated by lipid peroxidation.</p>","PeriodicalId":76727,"journal":{"name":"The science reports of the research institutes, Tohoku University. Ser. C, Medicine. Tohoku Daigaku","volume":"26 3-4","pages":"39-45"},"PeriodicalIF":0.0000,"publicationDate":"1979-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The science reports of the research institutes, Tohoku University. Ser. C, Medicine. Tohoku Daigaku","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Low concentration (0.1--1 mM) of ascorbate and erythorbate (isoascorbate) caused lipid peroxidation and lysosome labilization ("cofactor" action). In addition, they acted additively on microsomal NADPH oxidase-induced lipid peroxidation at the low concentration. The "cofactor" action, however, was dependent reciprocally on the density of lysosomes; the more dilute was the lysosomal fraction, the more susceptible the lysosomes were. On the other hand, ascorbate and erythorbate at concentration more than 1 mM inhibited microsomal NADPH oxidase-induced lipid peroxidation and lysosome labilization. Their antioxidant effect was revealed to be clear especially when the "cofactor" action was eliminated by such a basic protein as protamine. Considering that the "cofactor" action was observed only at the lower density of lysosomes and might be inhibited by physiologically occurring basic proteins, ascorbate and erythorbate may mostly act as antioxidant on lysosomes in vivo. Ascorbate- or erythorbate- induced lysosome labilization was certified to be mediated by lipid peroxidation.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
抗坏血酸和赤霉酸对大鼠肝溶酶体的双重作用。
低浓度(0.1- 1mm)的抗坏血酸和赤血酸(异抗坏血酸)引起脂质过氧化和溶酶体不稳定(“辅助因子”作用)。此外,它们在低浓度下对微粒体NADPH氧化酶诱导的脂质过氧化有加性作用。然而,“辅因子”的作用相互依赖于溶酶体的密度;溶酶体分数越稀释,溶酶体越敏感。另一方面,浓度大于1mm的抗坏血酸和赤全酸抑制微粒体NADPH氧化酶诱导的脂质过氧化和溶酶体的不稳定性。它们的抗氧化作用是明显的,特别是当“辅因子”作用被鱼精蛋白等基本蛋白消除时。考虑到“辅助因子”作用仅在较低密度的溶酶体中观察到,并且可能被生理性产生的碱性蛋白所抑制,抗坏血酸和赤全酸在体内可能主要作为溶酶体的抗氧化剂。抗坏血酸或赤霉酸诱导的溶酶体失稳被证实是由脂质过氧化介导的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Identification of the deterministic chaos in cardiovascular dynamics by the use of the non-linear mathematics. Tumor induction in mice administered neonatally with N-bis(2-hydroxypropyl)nitrosamine (BHPN). Effect of respiratory phases and gravity on mucociliary transport in the normal lungs. Sympathetic nerve activity during maintaining circulation with only left ventricular assist device. Hydrodynamic endurance test of the prosthetic valve used in the various types of the ventricular assist device.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1